Table 2.
Association between candidate genetic markers and continuity of healthy metabolic status in woman of Tehran cardio-metabolic genetic study with 15 years follow up.
| Sample | Gene | Chr | Marker | Base pair | Major/minor | OR | 95% CI | P-value | MAF |
|---|---|---|---|---|---|---|---|---|---|
| Female | FTO | 16 | rs1121980 | 53,775,335 | G/A | 2.12 | (1.03–2.75) | 0.03 | 0.39 |
| Female | TCF7L2 | 10 | rs7903146 | 112,998,590 | C/T | 0.22 | (0.05–0.93) | 0.04 | 0.35 |
| Menopause | SLC39A8 | 4 | rs13107325 | 102,267,552 | C/T | 0.27 | (0.07–0.97) | 0.04 | 0.04 |
| Non menopause | SLC39A8 | 4 | rs13107325 | 102,267,552 | C/T | 0.89 | (0.56–1.4) | 0.62 | 0.04 |
MAF minor allele frequency, Chr chromosome, OR odd ratio.